The Full Wiki

More info on Phosphodiesterase inhibitors

Top phosphodiesterase inhibitors (Trending topics)

Advertisements
  

The following are the current most viewed articles on Wikipedia within Wikipedia's Phosphodiesterase inhibitors category. Think of it as a What's Hot list for Phosphodiesterase inhibitors. More info »

This is a beta release and so the figures may be a day or two out of date. We'd love to get your thoughts.

Rank Topic Wikipedia views
1 Caffeine 15,566 Sparkline of topic views for 2 weeks
2 Theophylline 1,441 Sparkline of topic views for 2 weeks
3 Theobromine 1,190 Sparkline of topic views for 2 weeks
4 Dipyridamole 674 Sparkline of topic views for 2 weeks
5 Phosphodiesterase inhibitor 583 Sparkline of topic views for 2 weeks
6 Vinpocetine 477 Sparkline of topic views for 2 weeks
7 Aminophylline 438 Sparkline of topic views for 2 weeks
8 Papaverine 396 Sparkline of topic views for 2 weeks
9 Anagrelide 138 Sparkline of topic views for 2 weeks
10 Pimobendan 136 Sparkline of topic views for 2 weeks
11 Tofisopam 83 Sparkline of topic views for 2 weeks
12 Paraxanthine 80 Sparkline of topic views for 2 weeks
13 Doxofylline 73 Sparkline of topic views for 2 weeks
14 IBMX 70 Sparkline of topic views for 2 weeks
15 EHNA 27 Sparkline of topic views for 2 weeks
16 PF-2545920 14 Sparkline of topic views for 2 weeks
17 BAY 73-6691 14 Sparkline of topic views for 2 weeks
18 Dyphylline 14 Sparkline of topic views for 2 weeks
19 Vesnarinone 13 Sparkline of topic views for 2 weeks
20 BRL-50481 13 Sparkline of topic views for 2 weeks
21 Dipropylcyclopentylxanthine 8 Sparkline of topic views for 2 weeks

Subcategories

Parent categories


Encyclopedia

From Wikipedia, the free encyclopedia

The main article for this category is Phosphodiesterase inhibitor.

Subcategories

This category has only the following subcategory.

P

Pages in category "Phosphodiesterase inhibitors"

The following 33 pages are in this category, out of 33 total. This list may not reflect recent changes (learn more).

A

B

C

D

E

E cont.

H

I

L

M

P

P cont.

R

T

U

V


Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message